Latest Technology News

Australian Bond Exchange Holdings (ASX: ABE) announces the resignation of director Anthony Hartman and the appointment of Robert Shaw and Mark O’Leary to its board, signaling a strategic boost in expertise.

Nanoveu Limited has launched a $2.7 million capital raising via a share placement and a substantial options offer, pending shareholder approval for securities issued to its Executive Chairman. The prospectus outlines key risks and the impact on the company’s capital structure.

DigitalX Limited has significantly increased its Solana token holdings, marking a strategic pivot to yield-generating digital assets through staking. The company aims to leverage this move to enhance recurring revenue and support blockchain ecosystem growth.

Generation Development Group (GDG) has forged a strategic alliance with BlackRock, combining local market leadership with global investment expertise to develop innovative retirement income solutions for Australian retirees.

Sparc Technologies is progressing its innovative green hydrogen pilot plant and graphene-based anti-corrosion trials, supported by a recent A$2.7 million capital raise to accelerate commercialisation and R&D.

Pro Medicus Limited’s U.S. subsidiary, Visage Imaging, has landed a significant five-year, A$20 million contract to implement its cloud-based Visage 7 imaging platform at University of Iowa Health Care, marking a major step in cloud adoption for healthcare IT.

American Rare Earths reports high-grade rare earth oxide results from Wyoming's Cowboy State Mine, reinforcing its strategic position in the US critical minerals landscape.

Belararox Limited has entered a strategic option agreement with Minerals 260 to divest its Bullabulling gold and lithium tenements, refocusing its efforts on copper projects in Argentina and Botswana.

Algorae Pharmaceuticals has partnered with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its oncology pipeline development.

Nyrada’s experimental drug NYR-BI03 shows promising cardioprotective and anti-arrhythmic effects in animal models, reinforcing its potential as a treatment for acute myocardial infarction.

Aurora Labs has reached a critical design freeze milestone under its Australian Defence Force contract, advancing its novel 3D-printed propulsion system towards testing and validation phases.

Sparc Technologies has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a 28.6% discount, aiming to raise up to $500,000 to fund key growth initiatives.